Demand for Better In-Home Patient Monitoring to Drive 170 Million Smart Home Healthcare Shipments by 2030

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) — The smart home healthcare device segment continues to demonstrate strong growth opportunities. According to ABI Research, total shipments will increase from 124 million units in 2026 to 170 million by 2030, representing a Compound Annual Growth Rate (CAGR) of 8.1%. Key device categories include connected Continuous Glucose Monitors (CGMs), digital scales, Personal Emergency Response Systems (PERS) devices, baby monitors, and blood pressure monitors.

“Demand for better disease management and remote in-home monitoring solutions is driving interest in connected healthcare solutions,” said Matthias Foo, Principal Analyst at ABI Research. “The ability of these healthcare devices to work seamlessly with mobile applications on smartphones allows both patients and healthcare providers to easily track and monitor their health statuses, thereby improving the convenience and accuracy of data collection and analysis.”

The latest financial results from major vendors reinforce this trend. ResMed, a leader in connected sleep health solutions, reported strong revenue growth of 10% Year-on-Year (YoY) in 2025. Leading CGM player Dexcom reported full-year 2025 revenue was up 16% YoY, while Abbott Laboratories also reported over 10% YoY revenue growth in its ‘Medical Devices’ business unit.

In terms of connectivity, Bluetooth continues to be used predominantly as it enables healthcare devices to pair easily with smartphones. This technology also supports longer battery life, as compared to Wi-Fi solutions, which makes it ideal for connected healthcare use cases. Beyond connectivity, Bluetooth Channel Sounding (CS), a feature that supports accurate positioning, is also being positioned as an additional value-add for wearable healthcare devices that allow patient movements to be tracked easily.

There is also growing momentum for cellular-based healthcare devices. In April 2025, Medical Guardian introduced a new line of cellular-enabled Remote Patient Monitoring (RPM) devices, including blood pressure cuffs, pulse oximeters, and weight scales, that support continuous monitoring without reliance on Wi-Fi or smartphones. These devices are integrated into the company’s MGEngage360 health monitoring platform, enabling healthcare providers to track key health parameters and support chronic disease management.

These findings are from ABI Research’s Smart Home Healthcare market data report, part of its Smart Living & Consumer Technologies research service. The report provides detailed forecasts, market share analysis, and insights into key smart home healthcare device trends.

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info:

Global
Jason Scheer
Tel: +1.516.624.2558
pr@abiresearch.com


Primary Logo